Evidence map›Paper›PMID 21984738›Full record

ArticleThe Journal of infectious diseases2011

Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants.

Elizabeth P Ehlinger, Emily M Webster, Helen H Kang, Aislyn Cangialose, Adam C Simmons, Kimberly H Barbas, Sandra K Burchett, Mary L Gregory, Karen M Puopolo, Karen P Puopolo and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Breast Milk and COVID-19: What Do We Know?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. [Research advances in breast milk-acquired cytomegalovirus infection in premature infants].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2016
    Review
  17. Article
  18. Immunity to cytomegalovirus in early life.Frontiers in immunology · 2014
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
    Puopolo, Karen P [corrected to Puopolo, Karen M]
5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Elizabeth P EhlingerDivision of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Emily M Webster
Helen H Kang
Aislyn Cangialose
Adam C Simmons
Kimberly H Barbas
Sandra K Burchett
Mary L Gregory
Karen M Puopolo
Karen P Puopolo
Sallie R Permar
Clinical Research Management · USGlobal Viral · USBeth Israel Deaconess Medical Center · USBoston Children's Hospital · USBrigham and Women's Hospital · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
NCRR NIH HHS 1 UL1 RR 025758-01NCRR NIH HHS UL1 RR025758
6 · The paper itself

Abstract

introductionTransmission of cytomegalovirus (CMV) via breast milk can lead to severe acute illness in very low-birth-weight (VLBW) preterm infants. Although the majority of CMV-seropositive women shed CMV in milk, symptomatic postnatal infection of VLBW infants occurs infrequently, suggesting that virologic or immunologic factors in milk may be associated with the risk and severity of postnatal CMV infection.

methodsWe investigated the magnitude of CMV-specific cellular and humoral immune responses in milk of 30 seropositive mothers of VLWB preterm infants and assessed their relationship to milk CMV load and symptomatic CMV transmission.

resultsMilk immunoglobulin G (IgG) avidity was inversely correlated to milk CMV load (r = -0.47; P = .009). However, milk CMV load and CMV-specific cellular and humoral immune responses were similar in mothers of VLBW infants with and those without symptomatic postnatal CMV infection.

conclusionsSimilar immunologic parameters in milk of CMV-seropositive mothers of VLBW infants with and without symptomatic postnatal CMV infection indicate that screening milk by these parameters may not predict disease risk. However, the inverse correlation between milk CMV IgG avidity and CMV load may suggest that enhancement of maternal CMV-specific IgG responses could aid in reduction of CMV shedding into breast milk.

Indexed as

Infectious Disease Transmission, VerticalAdolescentAdultAntibody AffinityBreast FeedingCytomegalovirusCytomegalovirus InfectionsFemaleGestational AgeHumansImmunity, CellularImmunity, HumoralImmunoglobulin AImmunoglobulin GInfant, NewbornInfant, PrematureImmunoglobulin AImmunoglobulin G

Identifiers

PMID21984738
PMCPMC3203229
OpenAlexW2157510862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.